RxDoctor Payments Data

Dzung Dinh, MD

Neurological Surgery · Peoria, ILNPI 1679513642

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Aesculap Implant Systems, LLC accounts for 95.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $7,885 and has fallen 99.6% since, to $28 in 2025.

$16,470in general payments, 2019–2025

Across 29 payments — averaging $567.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aesculap Implant Systems, LLC$16K
  • Medtronic$376
  • Globus Medical$175
  • Stryker$120
  • Si-bone, Inc.$63
  • Abbott$24
$37,370in research payments, 2019–2025

Across 7 payments — averaging $5338.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mitsubishi Tanabe Pharma Development America, Inc.$27K
  • Tanabe Pharma America, Inc.$10K

What the payments were for

  • Consulting fees$8,67553%
  • Speaking & faculty fees$6,33638%
  • Travel & lodging$1871%
  • Food & beverage$1,2728%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Aesculap Implant Systems, LLC15$15,713
Medtronic(2 entities)8$376
Globus Medical3$175
Stryker1$120
Si-bone, Inc.1$63
Abbott1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,470 in reported general payments places this provider in the 75th percentile of 302 neurological surgery providers in Illinois.

See all neurological surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$167,883
Medicare patients
233
Services billed
547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin83$769
Diclofenac Sodium45$359
Cyclobenzaprine Hcl17$181
Methylprednisolone11$45

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →